CureRays emerged from the COVID-19 pandemic, determined to investigate and validate the historic use of low-dose radiation for benign, inflammatory, and infectious indications. Through clinical radiation medicine, expert consultancy, and clinical trials, CureRays aims to “follow the science” wherever it may lead. We passionately discover and expand horizons about the role therapeutic radiation to treat human diseases and improve medical care.
CureRays investigators pioneered the use of low-dose, lung-directed x-ray treatment for COVID-19-related pneumonia, which reduced oxygenation demand, altered the immune system, and reduced intubation rates against the cascading run-away immune effects of the SARS-CoV-2 virus, which caused the global pandemic.
With gratitude
That work owed a great deal to Dr. Khan, whose scientific guidance in the earliest days of the COVID trial — serving as our external advisor, when the questions were hardest and the answers least certain — was deeply appreciated. A mentor's willingness to think carefully alongside you, at exactly the moment when careful thinking is most difficult, is a rare gift. We are grateful for it, and it shaped how CureRays approaches evidence to this day.
Our Belief
We believe x-rays can cure cancer and more.
Our Purpose
We exist to expand access to innovative non-invasive x-ray therapy to all.
Our Promise
We promise to help keep cancer and arthritis away.
Our Mission
CureRays Radiation Medicine® is a multi-speciality medical team that embraces all aspects of radiation medicine, including traditional radiation oncology, diagnostic radiology, and radio-pharmaceuticals, but also radiation dermatology, radiation rheumatology, radiation cardiology, radiation immunology, and radiation for benign conditions. CureRays also offers screening, surveillance, and survivorship planning, imaging review, toxicity management, and comprehensive after-care for all cancer patients.
CureRays Radiation Consultants extends expertise through consultancies, offering supervisorial services for superficial therapeutic x-rays for dermatologic and rheumatologic and other cancerous and benign diseases. Utilizing its patent devices and innovated processes, consultant services extend to clinical research and innovative product development.
CureRays Research, Innovation, and Education (CureRIE) Institute prioritizes discovery through bench, translational, and clinical research to advance scientific understanding and patient treatment options. The CureRIE Institute educates and expands access through its formal instructional programs for learners and through philanthropic charities expanding access to x-ray therapy.
Meet the people behind CureRays
Get to know the radiation oncologists, primary-care physicians, and care team who will be by your side.